论文部分内容阅读
本文对重症肝炎8例,慢性活动性肝炎4例,肝炎后肝硬化3例共15例住院病人在一般保肝治疗基础上,应用前列腺素E_1治疗观察,治疗后60％以上病例食欲增加,黄疸减轻,腹水消退,血小板上升;80％病例谷丙转氨酶下降,患肝性脑病2例意识转清。重症肝炎病人存活率为87.5％(7/8),慢活肝及肝硬化病人治疗好转率为71.0％(5/7)。并对前列腺素E,治疗肝炎多方面肝保肝作用及治疗副反应进行了讨论。
In this paper, 8 cases of severe hepatitis, chronic active hepatitis in 4 cases, 3 cases of posthepatitis cirrhosis in 15 cases on the basis of the general hepatoprotective therapy, the application of Prostaglandin E_1 treatment, the treatment of more than 60% of cases increased appetite, jaundice Reduce ascites, platelets increased; 80% of cases of alanine aminotransferase decreased, hepatic encephalopathy 2 cases of consciousness clear. The survival rate of patients with severe hepatitis was 87.5% (7/8), and the improvement rate of patients with chronic liver disease and cirrhosis was 71.0% (5/7). And prostaglandin E, the treatment of hepatitis liver in many aspects of liver function and treatment side effects were discussed.